From GlobeNewswire

1. GlobeNewswire reports that the stock market saw a significant increase today, with the S&P 500 rising by 2% and the Dow Jones Industrial Average climbing by 300 points. This positive momentum was driven by strong corporate earnings and optimism around economic recovery.

2. According to GlobeNewswire, tech giant Apple announced a record-breaking quarter, with revenue reaching $111.4 billion, surpassing analysts’ expectations. The company also reported strong sales of its latest iPhone 12 models, highlighting continued demand for its products.

3. GlobeNewswire reveals that pharmaceutical company Pfizer posted better-than-expected earnings, with revenue of $11.68 billion in the fourth quarter. The company’s COVID-19 vaccine, developed in partnership with BioNTech, played a significant role in driving revenue growth.

4. In other news from GlobeNewswire, electric vehicle maker Tesla reported a profitable quarter, with revenue reaching $10.74 billion. The company also announced plans to ramp up production of its Model Y SUV and expand its presence in international markets, fueling investor optimism.: 2025-05-06 07:30:00

CorMedix Inc. reported a Q1 2025 net revenue of $39.1 million and adjusted EBITDA of $23.6 million, driven by successful implementation by outpatient dialysis customers. The Company’s net income was $20.6 million, with cash from operations at $19.7 million. The Phase 3 study for reducing CLABSIs in adult patients is underway.

In Q1 2025, CorMedix recorded $39.1 million in net revenue from DefenCath sales, resulting in a net income of $20.6 million. Operating expenses were $17.4 million, with R&D expenses at $3.2 million. Cash and short-term investments totaled $77.5 million at the end of March 2025, excluding restricted cash.

CorMedix will host a conference call on May 6, 2025, at 8:30 AM ET to discuss recent corporate developments and financial results. The Company believes it has sufficient resources to fund operations for at least twelve months from the issuance of the Quarterly Report on Form 10-Q.Visit www.cormedix.com for more information about CorMedix’s therapeutic products and development plans. CorMedix reported a net sales of $39,081,657 for the first quarter of 2025, with a gross income of $37,484,942. Operating expenses totaled $17,359,662, resulting in an income from operations of $20,125,280. The company’s net income for the quarter was $20,643,898.

The company’s balance sheet data as of March 31, 2025, shows total assets of $149,582,766, with cash, cash equivalents, and restricted cash totaling $66,390,985. Total liabilities were reported at $34,694,718, with total stockholders’ equity at $114,888,048.

For the first quarter of 2025, CorMedix reported net cash provided by operating activities of $19,736,503 and net cash used in investing activities of $194,820. Net cash provided by financing activities was $6,092,935, resulting in a net increase in cash and cash equivalents of $25,634,847.

CorMedix presented non-GAAP reconciliations for the first quarter of 2025, showing EBITDA at $20,249,050 and adjusted EBITDA at $23,603,429. Adjustments included stock-based compensation expense and restructuring expenses. These non-GAAP measures provide additional insights into the company’s financial performance.



Read more at GlobeNewswire

1. GlobeNewswire reports that the stock market saw a significant increase today, with the S&P 500 rising by 2% and the Dow Jones Industrial Average climbing by 300 points. This positive momentum was driven by strong corporate earnings and optimism around economic recovery.

2. According to GlobeNewswire, tech giant Apple announced a record-breaking quarter, with revenue reaching $111.4 billion, surpassing analysts’ expectations. The company also reported strong sales of its latest iPhone 12 models, highlighting continued demand for its products.

3. GlobeNewswire reveals that pharmaceutical company Pfizer posted better-than-expected earnings, with revenue of $11.68 billion in the fourth quarter. The company’s COVID-19 vaccine, developed in partnership with BioNTech, played a significant role in driving revenue growth.

4. In other news from GlobeNewswire, electric vehicle maker Tesla reported a profitable quarter, with revenue reaching $10.74 billion. The company also announced plans to ramp up production of its Model Y SUV and expand its presence in international markets, fueling investor optimism.:: CorMedix Inc. Reports First Quarter 2025 Financial Results